1

Nanobodies Revive tumor suppressor p53: A Potential Pathway for Malignant Management

News Discuss 
A major discovery in cancer research is emerging with the use of mini-antibodies to re-engage mutated p53. This vital cancer suppressor protein is frequently disabled in many forms of malignancies, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story